Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR

Clinical Laboratory

Volumn 58, Issue 5-6, 2012, Pages 433-439

  Bennour, Ayda ^a   Ouahchi, Ines ^a   Moez, Medhaffar ^b   Elloumi, Moez ^b   Khelif, Abderrahim ^a   Saad, Ali ^a   Sennana, Halima ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

BCR ABL transcript; Chronic myeloid leukemia; Multiplex RT PCR

Indexed keywords

BCR ABL PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUNISIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHILD; CHROMOSOME BANDING; CHROMOSOME BREAKPOINTS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84863637880     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-3.
3. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-84. (Pubitemid 26327486)
4. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988;319:990-8.
5. Saglio G, Guerrasio A, Rosso C, et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990;76:1819-24.
6. Van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukaemia for detection of minimal residual disease. Report of the BIOMOED-1 Concerted Action: investigation of minimal residual disease in acute leukaemia. Leukemia 1999;13:1901-28.
7. Byrne JL, Carter GI, Davies JM, Haynes AP, Russell NH, Cross NC. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukemia and an aggressive clinical course. Br J Haematol 1998;103:791-4. (Pubitemid 28545318)
8. Hochhaus A, Reiter A, Skladny H, et al. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood 1996;88:2236-40. (Pubitemid 26307927)
9. Branford S, Rudzki Z, Hughes TP. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron lb in a patient with Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 2000;109:635-7. (Pubitemid 30415193)
10. Afar DE, Goga A, McLaughlin J, Witte ON, Sawyers CL. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 1994;264:424.
11. Wang LY, Bagg A, Pear W, Peter C, Hess JL. Chronic myelogenous leukemia: laboratory diagnosis and monitoring. Genes Chromosomes Cancer 2001;32:97-111.
12. Hess JL. Detection of chromosomal translocations in Leukemia. Is there a best way? Am J Clin Pathol 1998;109:3-5.
13. Schultheis B, Wang L, Clark RE, Melo JV. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Leukemia 2003;17:2054-5. (Pubitemid 37322139)
14. Lee JJ, Kim HJ, Kim YJ, et al. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts. Leukemia 2004;18:1539-40.
15. Mondai BC, Majumdar S, Dasgupta UB, et al. e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases. J Clin Pathol 2006;59:1102-3. (Pubitemid 44570338)
16. ISCN. 2005: An International System for Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, editors. Karger, 2005.
17. Burmeister T, Maurer J, Aivado M, et al. Quality assurance in RTPCR- based BCR/ABL diagnostics - results of an interlaboratory test and a standardization approach. Leukemia 2000;14:1850-6.
18. Cross N, Melo J, Feng L, Goldman J. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNA in hematological disorders. Leukemia 1994;8:186-9. (Pubitemid 24032839)
19. Goh HG, Hwang JI Y, Kim SH, Lee YH, Kim YL, Kim DW. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR. Translational Research 2006;148:249-55.
20. Osman EAI, Hamad K, Elmula IMF, Ibrahim ME. Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients. Genet Mol Biol 2010;33(2):229-31.
21. Burmeister T, Schwartz S, Taubald A, et al. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica 2007;92:1699-702. (Pubitemid 350248252)
22. Bennour A, Beaufils N, Sennana H, Meddeb B, Saad A, Gabert J. E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. J Clin Pathol 2010;63:737-40.
23. Andrikovics H, Nahajevszky S, Szilvási A, et al. First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare ela2 or e19a2 BCR-ABL transcripts. Hematol Oncol 2007;25:143-7. (Pubitemid 47507883)
24. Emig M, Saussele S, Wittor H, et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999;13:1825-32. (Pubitemid 29535267)
25. Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009;27:6041-51.
26. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer program. Leukemia 2003;17:2318-57. (Pubitemid 38072573)
27. Hughes T, Deininger M, Hochhaus A, et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006;108:28-37. (Pubitemid 43990609)
28. Cross NC. Standardisation of molecular monitoring for chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009;22:355-65.